Samantha McLemore’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109M Buy
19,036,976
+1,219,589
+7% +$5.27M 3.56% 12
2026
Q1
$69M Sell
17,817,387
-856,079
-5% -$3.51M 2.52% 18
2025
Q4
$78.1M Sell
18,673,466
-7,787,382
-29% -$30.1M 3.01% 14
2025
Q3
$87.1M Buy
26,460,848
+10,192,107
+63% +$28.8M 3.48% 12
2025
Q2
$23.1M Sell
16,268,741
-1,103,560
-6% -$1.57M 1.04% 32
2025
Q1
$25.9M Sell
17,372,301
-508,945
-3% -$801K 1.33% 30
2024
Q4
$20M Sell
17,881,246
-56,448
-0.3% -$48.1K 0.92% 32
2024
Q3
$17M Sell
17,937,694
-236,964
-1% -$299K 0.83% 34
2024
Q2
$28.7M Buy
18,174,658
+721,203
+4% +$1.05M 1.53% 28
2024
Q1
$25.3M Buy
17,453,455
+1,469,755
+9% +$2.11M 1.23% 34
2023
Q4
$21.4M Buy
15,983,700
+2,230,524
+16% +$2.62M 1.13% 32
2023
Q3
$19.5M Buy
13,753,176
+2,509,616
+22% +$3.56M 1.15% 34
2023
Q2
$12.9M Buy
11,243,560
+9,779,800
+668% +$11.5M 0.72% 33
2023
Q1
$1.55M Buy
1,463,760
+665,560
+83% +$960K 0.69% 37
2022
Q4
$1.21M Buy
798,200
+500,000
+168% +$860K 0.59% 39
2022
Q3
$632K Hold
298,200
0.32% 41
2022
Q2
$400K Hold
298,200
0.18% 42
2022
Q1
$629K Hold
298,200
0.21% 45
2021
Q4
$1.11M Buy
+298,200
New +$1.28M 0.32% 43

Other funds holding PGEN

Samantha McLemore's PGEN Position: Q2 2026 in Review

Samantha McLemore increased its Precigen (PGEN) stake by 6.8% in Q2 2026, buying an estimated $5.27M and bringing the position to 19,036,976 shares worth $109M. The position accounts for 3.56% of the portfolio, ranked #12.

Samantha McLemore first reported a position in PGEN in Q4 2021 and has held it in 19 quarters since. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Samantha McLemore held 19,036,976 shares of Precigen worth $109M as of Q2 2026.
  • Samantha McLemore bought 1,219,589 Precigen shares in Q2 2026, an estimated $5.27M.
  • Precigen made up 3.56% of Samantha McLemore's portfolio in Q2 2026, its #12 holding.
  • Samantha McLemore first reported a position in Precigen in Q4 2021 and has held it in 19 quarters since.
  • 209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.